Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire

被引：0
|
作者：
Nanno Schreuder
Quincy de Hoog
Sieta T. de Vries
Pieter L. Jager
Jos G. W. Kosterink
Eugène P. van Puijenbroek
机构：
[1] Groningen Research Institute of Pharmacy,Unit of PharmacoTherapy,
[2] University of Groningen,Epidemiology and
[3] GE Healthcare Radiopharmacy Zwolle,Economics
[4] University of Groningen,Department of Clinical Pharmacy and Pharmacology
[5] University Medical Center Groningen,Department of Nuclear Medicine
[6] Isala Hospital,undefined
[7] Netherlands Pharmacovigilance Centre Lareb,undefined
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：319 / 328
页数：9
相关论文
共 50 条
  • [1] Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
    Schreuder, Nanno
    de Hoog, Quincy
    de Vries, Sieta T.
    Jager, Pieter L.
    Kosterink, Jos G. W.
    van Puijenbroek, Eugene P.
    DRUG SAFETY, 2020, 43 (04) : 319 - 328
  • [2] Patient-reported adverse events of diagnostic radiopharmaceuticals
    Schreuder, N.
    Jager, P. L.
    Kosterink, J. G. W.
    van Puijenbroek, E. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S735 - S736
  • [3] Development and Content Validation of a Patient-Reported Adverse Drug Event Questionnaire
    de Vries, S. T.
    Haaijer-Ruskamp, F. M.
    de Zeeuw, D.
    Denig, P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 224 - 224
  • [4] Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire
    Sieta T. de Vries
    Peter G. M. Mol
    Dick de Zeeuw
    Flora M. Haaijer-Ruskamp
    Petra Denig
    Drug Safety, 2013, 36 : 765 - 777
  • [5] Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire
    de Vries, Sieta T.
    Mol, Peter G. M.
    de Zeeuw, Dick
    Haaijer-Ruskamp, Flora M.
    Denig, Petra
    DRUG SAFETY, 2013, 36 (09) : 765 - 777
  • [6] Development and Content Validation of a Patient-Reported Adverse Drug Event Questionnaire
    de Vries, S. T.
    Mol, P. G. M.
    de Zeeuw, D.
    Haaijer-Ruskamp, F. M.
    Denig, P.
    DRUG SAFETY, 2012, 35 (10) : 900 - 900
  • [7] Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
    Schreuder, Nanno
    Jacobs, Niels A.
    Jager, Pieter L.
    Kosterink, Jos G. W.
    van Puijenbroek, Eugene P.
    DRUG SAFETY, 2021, 44 (02) : 211 - 222
  • [8] Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
    Nanno Schreuder
    Niels A. Jacobs
    Pieter L. Jager
    Jos G. W. Kosterink
    Eugène P. van Puijenbroek
    Drug Safety, 2021, 44 : 211 - 222
  • [9] PATIENT-REPORTED ADVERSE EVENTS
    Nakajima, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 75 - 75
  • [10] Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation
    Morlock, Robert
    Wirth, R. J.
    Tally, Steven R.
    Garufis, Carrie
    Heichel, Christopher W. D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 178 : 101 - 114
12345